참고문헌
- Smith A, Egan J, Ridley G, Haan E, Montgomery P, Williams K, et al. Birth prevalence of Prader-Willi syndrome in Australia. Arch Dis Child 2003;88:263-4. https://doi.org/10.1136/adc.88.3.263
- Vogels A, Van Den Ende J, Keymolen K, Mortier G, Devriendt K, Legius E, et al. Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur J Hum Genet 2004;12:238-40. https://doi.org/10.1038/sj.ejhg.5201135
- Cassidy SB, Dykens E, Williams CA. Prader-Willi and Angelman syndromes: sister imprinted disorders. Am J Med Genet 2000;97:136-46. https://doi.org/10.1002/1096-8628(200022)97:2<136::AID-AJMG5>3.0.CO;2-V
- Glenn CC, Driscoll DJ, Yang TP, Nicholls RD. Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes. Mol Hum Reprod 1997;3:321-32. https://doi.org/10.1093/molehr/3.4.321
- Glenn CC, Saitoh S, Jong MT, Filbrandt MM, Surti U, Driscoll DJ, et al. Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene. Am J Hum Genet 1996;58:335-46.
- Kubota T, Das S, Christian SL, Baylin SB, Herman JG, Ledbetter DH. Methylation-specific PCR simplifies imprinting analysis. Nat Genet 1997; 16:16-7. https://doi.org/10.1038/ng0597-16
- Burman P, Ritzen EM, Lindgren AC. Endocrine dysfunction in Prader- Willi syndrome: a review with special reference to GH. Endocr Rev 2001; 22:787-99. https://doi.org/10.1210/er.22.6.787
- Butler MG, Meaney FJ. Standards for selected anthropometric measurements in Prader-Willi syndrome. Pediatrics 1991;88:853-60.
- Eiholzer U, Bachmann S, l'Allemand D. Is there growth hormone deficiency in prader-willi Syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader-Willi syndrome. Horm Res 2000;53 Suppl 3:44-52.
- Eiholzer U, l'Allemand D. Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after 4 years of therapy. Horm Res 2000;53:185-92. https://doi.org/10.1159/000023565
- Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, et al. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome. Clin Endocrinol (Oxf) 2008;69:443-51. https://doi.org/10.1111/j.1365-2265.2008.03228.x
- Lin HY, Lin SP, Tsai LP, Chao MC, Chen MR, Chuang CK, et al. Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome. J Chin Med Assoc 2008;71:305-9. https://doi.org/10.1016/S1726-4901(08)70127-8
- Angulo MA, Castro-Magana M, Lamerson M, Arguello R, Accacha S, Khan A. Final adult height in children with Prader-Willi syndrome with and without human growth hormone treatment. Am J Med Genet A 2007;143A:1456-61. https://doi.org/10.1002/ajmg.a.31824
- Myers SE, Carrel AL, Whitman BY, Allen DB. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr 2000; 137:42-9. https://doi.org/10.1067/mpd.2000.105369
- Carrel AL, Moerchen V, Myers SE, Bekx MT, Whitman BY, Allen DB. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. J Pediatr 2004;145:744-9. https://doi.org/10.1016/j.jpeds.2004.08.002
- Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB. Two years of growth hormone therapy in young children with Prader- Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 2007;143:443-8.
- Tauber M, Diene G, Molinas C, Hebert M. Review of 64 cases of death in children with Prader-Willi syndrome (PWS). Am J Med Genet A 2008; 146:881-7.
- Grugni G, Crino A, Bosio L, Corrias A, Cuttini M, De Toni T, et al. The Italian National Survey for Prader-Willi syndrome: an epidemiologic study. Am J Med Genet A 2008;146:861-72.
- Sacca L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev 1994;15:555-73. https://doi.org/10.1210/edrv-15-5-555
- Hauffa BP, Knaup K, Lehmann N, Neudorf U, Nagel B. Effects of growth hormone therapy on cardiac dimensions in children and adolescents with Prader-Willi syndrome. Horm Res Paediatr 2011;75:56-62. https://doi.org/10.1159/000319612
- Festen DA, Wevers M, Lindgren AC, Bohm B, Otten BJ, Wit JM, et al. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin Endocrinol (Oxf) 2008;68:919-25. https://doi.org/10.1111/j.1365-2265.2007.03126.x
- Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome. J Clin Endocrinol Metab 2010;95:1131-6. https://doi.org/10.1210/jc.2009-1389
- Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007;13:332-9. https://doi.org/10.1038/nm1557
- Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006;580:2917-21. https://doi.org/10.1016/j.febslet.2006.04.028
- Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-83. https://doi.org/10.1038/nri1937
- Alberti L, Gilardini L, Girola A, Moro M, Cavagnini F, Invitti C. Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients. Diabetes Obes Metab 2007;9:344-9. https://doi.org/10.1111/j.1463-1326.2006.00614.x
- Vuorela P, Ala-Mello S, Saloranta C, Penttinen M, Poyhonen M, Huoponen K, et al. Molecular analysis of the CHD7 gene in CHARGE syndrome: identification of 22 novel mutations and evidence for a low contribution of large CHD7 deletions. Genet Med 2007;9:690-4. https://doi.org/10.1097/GIM.0b013e318156e68e
- Butler MG, Fischer W, Kibiryeva N, Bittel DC. Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet A 2008;146:854-60.
- Colmenares A, Pinto G, Taupin P, Giuseppe A, Odent T, Trivin C, et al. Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome. Horm Res Paediatr 2011;75:123-30. https://doi.org/10.1159/000319709
- de Lind van Wijngaarden RF, de Klerk LW, Festen DA, Hokken-Koelega AC. Scoliosis in Prader-Willi syndrome: prevalence, effects of age, gender, body mass index, lean body mass and genotype. Arch Dis Child 2008;93: 1012-6. https://doi.org/10.1136/adc.2007.123836
- Nagai T, Obata K, Ogata T, Murakami N, Katada Y, Yoshino A, et al. Growth hormone therapy and scoliosis in patients with Prader-Willi syndrome. Am J Med Genet A 2006;140:1623-7.
- Odent T, Accadbled F, Koureas G, Cournot M, Moine A, Diene G, et al. Scoliosis in patients with Prader-Willi Syndrome. Pediatrics 2008;122: e499-503. https://doi.org/10.1542/peds.2007-3487
- Ahl T, Albertsson-Wikland K, Kalen R. Twenty-four-hour growth hormone profiles in pubertal girls with idiopathic scoliosis. Spine (Phila Pa 1976) 1988;13:139-42. https://doi.org/10.1097/00007632-198802000-00001
- Skogland LB, Miller JA. Growth related hormones in idiopathic scoliosis. An endocrine basis for accelerated growth. Acta Orthop Scand 1980;51:779-80. https://doi.org/10.3109/17453678008990874
- Willner S, Nilsson KO, Kastrup K, Bergstrand CG. Growth hormone and somatomedin A in girls with adolescent idiopathic scoliosis. Acta Paediatr Scand 1976;65:547-52. https://doi.org/10.1111/j.1651-2227.1976.tb04930.x
- de Lind van Wijngaarden RF, de Klerk LW, Festen DA, Duivenvoorden HJ, Otten BJ, Hokken-Koelega AC. Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome. J Clin Endocrinol Metab 2009; 94:1274-80. https://doi.org/10.1210/jc.2008-1844
- Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 1999; 159(5 Pt 1):1527-32. https://doi.org/10.1164/ajrccm.159.5.9809079
- Richards A, Quaghebeur G, Clift S, Holland A, Dahlitz M, Parkes D. The upper airway and sleep apnoea in the Prader-Willi syndrome. Clin Otolaryngol Allied Sci 1994;19:193-7. https://doi.org/10.1111/j.1365-2273.1994.tb01213.x
- Schluter B, Buschatz D, Trowitzsch E, Aksu F, Andler W. Respiratory control in children with Prader-Willi syndrome. Eur J Pediatr 1997; 156:65-8. https://doi.org/10.1007/s004310050555
- Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91:398-402.
- Eiholzer U. Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res 2005;63:33-9. https://doi.org/10.1159/000082745
- Fillion M, Deal C, Van Vliet G. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome. J Pediatr 2009;154:230-3. https://doi.org/10.1016/j.jpeds.2008.07.058
- Nixon GM, Rodda CP, Davey MJ. Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader- Willi syndrome. J Clin Endocrinol Metab 2011;96:29-33. https://doi.org/10.1210/jc.2010-1445
- Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 2004;36:720-4. https://doi.org/10.1038/ng1379
- Park SW, Lee ST, Sohn YB, Kim SH, Cho SY, Ko AR, et al. A polymorphism in the growth hormone receptor is associated with height in children with Prader-Willi syndrome. Am J Med Genet A 2011;155A:2970-3.
- Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold JA, Kimonis V, et al. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A 2011;155A:1040-9.
- McAllister CJ, Whittington JE, Holland AJ. Development of the eating behaviour in Prader-Willi Syndrome: advances in our understanding. Int J Obes (Lond) 2011;35:188-97. https://doi.org/10.1038/ijo.2010.139
- Brandau DT, Lund M, Cooley LD, Sanger WG, Butler MG. Autistic and dysmorphic features associated with a submicroscopic 2q33.3-q34 interstitial deletion detected by array comparative genomic hybridization. Am J Med Genet A 2008;146A:521-4. https://doi.org/10.1002/ajmg.a.32153
- Sahoo T, Bacino CA, German JR, Shaw CA, Bird LM, Kimonis V, et al. Identification of novel deletions of 15q11q13 in Angelman syndrome by array-CGH: molecular characterization and genotype-phenotype correlations. Eur J Hum Genet 2007;15:943-9. https://doi.org/10.1038/sj.ejhg.5201859
- Santamaria R, Blanco M, Chabas A, Grinberg D, Vilageliu L. Identification of 14 novel GLB1 mutations, including five deletions, in 19 patients with GM1 gangliosidosis from South America. Clin Genet 2007;71:273-9. https://doi.org/10.1111/j.1399-0004.2007.00767.x
- Butler JV, Whittington JE, Holland AJ, McAllister CJ, Goldstone AP. The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood. Dev Med Child Neurol 2010;52:e88-93. https://doi.org/10.1111/j.1469-8749.2009.03530.x
- Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken- Koelega AC. Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. J Clin Endocrinol Metab 2012;97:E452-9. https://doi.org/10.1210/jc.2011-1954
- Eldar-Geva T, Hirsch HJ, Rabinowitz R, Benarroch F, Rubinstein O, Gross-Tsur V. Primary ovarian dysfunction contributes to the hypogonadism in women with Prader-Willi Syndrome. Horm Res 2009; 72:153-9. https://doi.org/10.1159/000232489
- Unanue N, Bazaes R, Iniguez G, Cortes F, Avila A, Mericq V. Adrenarche in Prader-Willi syndrome appears not related to insulin sensitivity and serum adiponectin. Horm Res 2007;67:152-8. https://doi.org/10.1159/000096742
- Crino A, Di Giorgio G, Schiaffini R, Fierabracci A, Spera S, Maggioni A, et al. Central precocious puberty and growth hormone deficiency in a boy with Prader-Willi syndrome. Eur J Pediatr 2008;167:1455-8. https://doi.org/10.1007/s00431-008-0679-0
- Vaiani E, Herzovich V, Chaler E, Chertkoff L, Rivarola MA, Torrado M, et al. Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life. Clin Endocrinol (Oxf) 2010;73:546-50.
- Festen DA, Visser TJ, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken- Koelega AC. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. Clin Endocrinol (Oxf) 2007;67:449-56. https://doi.org/10.1111/j.1365-2265.2007.02910.x
- Nagai T, Obata K, Tonoki H, Temma S, Murakami N, Katada Y, e al. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 2005; 136:45-8.
- Einfeld SL, Kavanagh SJ, Smith A, Evans EJ, Tonge BJ, Taffe J. Mortality in Prader-Willi syndrome. Am J Ment Retard 2006;111:193-8. https://doi.org/10.1352/0895-8017(2006)111[193:MIPS]2.0.CO;2
- Corrias A, Grugni G, Crino A, Di Candia S, Chiabotto P, Cogliardi A, et al. Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome. Clin Endocrinol (Oxf) 2012;76:843-50. https://doi.org/10.1111/j.1365-2265.2011.04313.x
피인용 문헌
- Growth Hormone Treatment and Its Effect on Height in Pediatric Patients with Different Genotypes of Prader-Willi Syndrome vol.17, pp.3, 2012, https://doi.org/10.6065/apem.2012.17.3.175
- Prader-Willi syndrome: new possibilities for its treatment in the children vol.59, pp.4, 2012, https://doi.org/10.14341/probl201359433-40
- Prader-Willi syndrome: a single center's experience in Korea vol.57, pp.7, 2012, https://doi.org/10.3345/kjp.2014.57.7.310
- Disease‐specific growth charts for Korean infants with Prader–Willi syndrome vol.167, pp.1, 2015, https://doi.org/10.1002/ajmg.a.36816
- Growth Hormone Therapy in Adults with Prader-Willi Syndrome vol.1, pp.2, 2015, https://doi.org/10.19125/jmrd.2015.1.2.49
- Introduction to the New Version of PWS Application and It's Use in Medical Practice vol.2, pp.2, 2012, https://doi.org/10.19125/jmrd.2016.2.2.41
- Prader-Willi Syndrome: Background and Management vol.36, pp.3, 2012, https://doi.org/10.1891/0730-0832.36.3.134
- Beneficial Effects of Growth Hormone Treatment in Prader-Willi Syndrome vol.3, pp.2, 2012, https://doi.org/10.19125/jmrd.2017.3.2.41
- Growth Hormone Therapy in PWS with Mobile Application-Living with PWS vol.4, pp.2, 2012, https://doi.org/10.19125/jmrd.2018.4.2.42
- Prader-Willi syndrome: endocrine manifestations and management vol.64, pp.3, 2012, https://doi.org/10.20945/2359-3997000000248